IL-17 Expression in the Time Course of Acute Anti-Thy1 Glomerulonephritis

PLoS One. 2016 May 31;11(5):e0156480. doi: 10.1371/journal.pone.0156480. eCollection 2016.

Abstract

Background: Interleukin-17 (IL-17) is a new pro-inflammatory cytokine involved in immune response and inflammatory disease. The main source of IL-17 is a subset of CD4+ T-helper cells, but is also secreted by non-immune cells. The present study analyzes expression of IL-17 in the time course of acute anti-thy1 glomerulonephritis and the role of IL-17 as a potential link between inflammation and fibrosis.

Methods: Anti-thy1 glomerulonephritis was induced into male Wistar rats by OX-7 antibody injection. After that, samples were taken on days 1, 5, 10 (matrix expansion phase), 15 and 20 (resolution phase). PBS-injected animals served as controls. Proteinuria and histological matrixes score served as the main markers for disease severity. In in vitro experiments, NRK-52E cells were used. For cytokine expressions, mRNA and protein levels were analyzed by utilizing RT-PCR, in situ hybridization and immunofluorescence.

Results: Highest IL-17 mRNA-expression (6.50-fold vs. con; p<0.05) was found on day 5 after induction of anti-thy1 glomerulonephritis along the maximum levels of proteinuria (113 ± 13 mg/d; p<0.001), histological glomerular-matrix accumulation (82%; p<0.001) and TGF-β1 (2.2-fold; p<0.05), IL-6 mRNA expression (36-fold; p<0.05). IL-17 protein expression co-localized with the endothelial cell marker PECAM in immunofluorescence. In NRK-52E cells, co-administration of TGF-β1 and IL-6 synergistically up-regulated IL-17 mRNA 4986-fold (p<0.001).

Conclusions: The pro-inflammatory cytokine IL-17 is up-regulated in endothelial cells during the time course of acute anti-thy1 glomerulonephritis. In vitro, NRK-52E cells secrete IL-17 under pro-fibrotic and pro-inflammatory conditions.

MeSH terms

  • Animals
  • Cell Line
  • Disease Models, Animal
  • Glomerulonephritis / etiology
  • Glomerulonephritis / genetics
  • Glomerulonephritis / immunology*
  • Interleukin-17 / genetics*
  • Interleukin-17 / metabolism*
  • Interleukin-6 / administration & dosage
  • Interleukin-6 / genetics
  • Isoantibodies / metabolism*
  • Male
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Transforming Growth Factor beta1 / administration & dosage
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism
  • Up-Regulation

Substances

  • Il17a protein, rat
  • Interleukin-17
  • Interleukin-6
  • Isoantibodies
  • RNA, Messenger
  • Tgfb1 protein, rat
  • Transforming Growth Factor beta1
  • anti-Thy antibody

Grants and funding

The authors received no specific funding for this work.